Lacerta Therapeutics’ Capsid Licensing and Research Collaboration Agreement with Prevail Therapeutics.

Goodwin Procter advised Lacerta Therapeutics on the deal.Lacerta Therapeutics announced its AAV capsid licensing and research collaboration agreement with Prevail Therapeutics. As a part of the…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now